STING agonists as promising vaccine adjuvants to boost immunogenicity against SARS-related coronavirus derived infection: possible role of autophagy

Aysa Rezabakhsh,M. Reza Sadaie,Alireza Ala,Yousef Roosta,Solomon Habtemariam,Adeleh Sahebnasagh,Mohammad Rafi Khezri

DOI: https://doi.org/10.1186/s12964-024-01680-0

IF: 7.525

2024-06-04

Cell Communication and Signaling

Abstract:As a major component of innate immunity and a positive regulator of interferons, the Stimulator of interferon gene (STING) has an immunotherapy potential to govern a variety of infectious diseases. Despite the recent advances regarding vaccines against COVID-19, nontoxic novel adjuvants with the potential to enhance vaccine efficacy are urgently desired. In this connection, it has been well-documented that STING agonists are applied to combat COVID-19. This approach is of major significance for boosting immune responses most likely through an autophagy-dependent manner in susceptible individuals against infection induced by severe acute respiratory syndrome Coronavirus (SARS‐CoV‐2). Given that STING agonists exert substantial immunomodulatory impacts under a wide array of pathologic conditions, these agents could be considered novel adjuvants for enhancing immunogenicity against the SARS-related coronavirus. Here, we intend to discuss the recent advances in STING agonists' recruitment to boost innate immune responses upon vaccination against SARS-related coronavirus infections. In light of the primordial role of autophagy modulation, the potential of being an antiviral vaccine adjuvant was also explored.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the potential of STING agonists as vaccine adjuvants in enhancing the immunogenicity against SARS - related coronavirus infections, and the possible role of autophagy in this process. Specifically, the paper focuses on the following aspects:

1. **Mechanism of action of STING agonists**: Explore how STING agonists enhance the immune response by activating the STING signaling pathway, especially the immune response against the SARS - CoV - 2 virus.

2. **Role of autophagy in antiviral immunity**: Analyze how autophagy enhances the immune effect of vaccines by degrading virus particles and promoting antigen presentation, especially in SARS - CoV - 2 infection.

3. **Interaction between STING agonists and autophagy**: Study how STING agonists further enhance the immunogenicity of vaccines by regulating the autophagy process, thereby improving the protective effect of vaccines against SARS - CoV - 2.

4. **Potential of STING agonists as novel vaccine adjuvants**: Evaluate the possibility of STING agonists as novel vaccine adjuvants, especially in the context of the current urgent need for new adjuvants that are non - toxic and can enhance vaccine efficacy.

By reviewing the latest progress of STING signaling pathway and autophagy in antiviral immunity, the paper aims to provide theoretical basis and technical support for the development of more effective SARS - CoV - 2 vaccines.